PRESS RELEASE

HER2DX® recognized by TIME as one of the Best Inventions of 2022

NEWS

Reveal Genomics, Dana-Farber Using HER2DX to Analyze Data in Three Breast Cancer Trials

BLOG

Our thoughts about REVEAL GENOMICS creation: A new approach to Physicians and Patients

Learn more

PRESS RELEASES

HER2DX® recognized by TIME as one of the Best Inventions of 2022

REVEAL GENOMICS® announces positive top-line results for HER2DX® in APT and ATEMPT trials

First clinical impact data of HER2DX® according to two independent studies presented at the SEOM congress

Primeros datos de impacto clínico del HER2DX®️ según dos estudios independientes presentados en el Congreso de la SEOM

Strategic partnership between MEDSIR and REVEAL GENOMICS® for cancer research

Alianza estratégica entre MEDSIR y REVEAL GENOMICS® para investigar contra el cáncer

ESMO 2022: REVEAL GENOMICS®️ presents new validation data of HER2DX®️ in the PerELISA trial

Reveal Genomics y HM Hospitales firman un acuerdo para ofrecer el test genómico HER2DX®️ en su portfolio

Reveal Genomics Announces Research Collaboration in HER2+ Breast Cancer

REVEAL GENOMICS® Markets HER2DX®, The World's First Genomic Test for Personalized HER2+ Breast Cancer Treatment

HER2DX: First genomic test for personalized HER2+ breast cancer treatments

REVEAL GENOMICS APPOINTS PATRICIA VILLAGRASA-GONZÁLEZ CHIEF EXECUTIVE OFFICER

SPIN OFF-REVEAL GENOMICS EMERGES TO DEVELOP INNOVATIVE DIAGNOSTICS TESTS IN ONCOLOGY

Reveal Genomics, Dana-Farber Using HER2DX to Analyze Data in Three Breast Cancer Trials

Reveal Genomics Introduces HER2DX Breast Cancer Test in Europe, Plans US Expansion

Un test genómico mejora el tratamiento de uno de cada cinco cánceres de mama

Aleix Prat: «As an oncologist, what I want is for these instruments to be available for use in our practices"

REVEAL GENOMICS FICHA EN SOLTI A SU NUEVA CONSEJERA DELEGADA

"MANY MORE ROLE MODELS ARE NEEDED" WOMEN'S PRESENCE IN THE CATALAN BIOMEDICAL ECOSYSTEM

INVESTIGADORES DEL CLINIC Y EL VALL D'HEBRON CREAN LA BIOTECNOLOGICA REVEAL GENOMICS

INVESTIGADORES DEL HOSPITAL CLINIC Y LA VALL D'HEBRON SE UNEN PARA LA DETECCIÓN PRECOZ DEL CÁNCER DE MAMA

SPANISH STARTUP AIMS TO DEVELOP GENOMIC TESTS TO GUIDE BREAST CANCER TREATMENTS

Our thoughts about REVEAL GENOMICS creation: A new approach to Physicians and Patients

news

blog